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kDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CaliforniaABSTRACT The ability to stimulate mammalian cells with light has significantly changed our understanding of electrically excit-
able tissues in health and disease, paving the way toward various novel therapeutic applications. Here, we demonstrate the
potential of optogenetic control in cardiac cells using a hybrid experimental/computational technique. Experimentally, we intro-
duced channelrhodopsin-2 into undifferentiated human embryonic stem cells via a lentiviral vector, and sorted and expanded the
genetically engineered cells. Via directed differentiation, we created channelrhodopsin-expressing cardiomyocytes, which we
subjected to optical stimulation. To quantify the impact of photostimulation, we assessed electrical, biochemical, andmechanical
signals using patch-clamping, multielectrode array recordings, and video microscopy. Computationally, we introduced channel-
rhodopsin-2 into a classic autorhythmic cardiac cell model via an additional photocurrent governed by a light-sensitive gating
variable. Upon optical stimulation, the channel opens and allows sodium ions to enter the cell, inducing a fast upstroke of the
transmembrane potential. We calibrated the channelrhodopsin-expressing cell model using single action potential readings
for different photostimulation amplitudes, pulse widths, and frequencies. To illustrate the potential of the proposed approach,
we virtually injected channelrhodopsin-expressing cells into different locations of a human heart, and explored its activation
sequences upon optical stimulation. Our experimentally calibrated computational toolbox allows us to virtually probe landscapes
of process parameters, and identify optimal photostimulation sequences toward pacing hearts with light.INTRODUCTIONFor more than 40 years, biologists have studied microorgan-
isms that produce proteins to directly regulate the flow of
charged ions across their plasma membrane in response to
light. The first identified protein of this kind was the light-
gated ion pump bacteriorhodopsin, transporting positively
charged hydrogen ions across the cell membrane (1). While
bacteriorhodopsin naturally acts as an on-switch for electri-
cally active cells, the second reported light-gated ion pump,
halorhodopsin, transports negatively charged chloride ions,
thereby acting as an off-switch (2). The first reported
light-gated ionic channel illustrated in Fig. 1, channelrho-
dopsin, was only identified 30 years later (3,4), but has since
revolutionized neuroscience.
Since the early 1990s, we have known that phototaxis and
photophobic responses in the green alga Chlamydomonas
reinhardtii are mediated by rhodopsins with a microbial-
type all-trans retinal chromosphore (5,6). The photochem-
ical isomerization of this all-trans retinal to 13-cis retinal
is illustrated in Fig. 2. It occurs at peak absorption wave-
lengths of 470 nm, opening the channel to sodium, potas-
sium, and calcium cations in response to blue light. In the
dark, the covalently bound retinal spontaneously relaxes toSubmitted April 29, 2011, and accepted for publication August 1, 2011.
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of the chromophore.
A breakthrough-enabling technology was reported in
2005, when the light-sensitive target was first introduced
genetically using engineered viruses (7,8), a technique that
is now known as optogenetics (9,10). Since then, optical
tools for controlling the electrical activity of neurons have
rapidly evolved, and are now gaining widespread use in
neuronal research and medicine (11,12). Although initial
applications of optogenetics have been restricted exclu-
sively to the neuronal system, optogenetic tools have now
advanced to a level of maturity, where they can confidently
be applied to other cells and organs (9). Natural first candi-
dates of choice are stem cells, and electrically active glial
cells, muscle cells, and cardiac cells (O. Abilez, J. A. Baugh,
M. L. Gorrepati, R. Prakash, C. Lee-Messer, M. Huang, F.
Jia, J. Yu, K. D. Wilson, J. C. Wu, K. Deisseroth, and C.
K. Zarins, unpublished; and (14)).
The objective of this study is to demonstrate the potential
of optogenetic control of the cardiac system using a hybrid
experimental/computational technique. We demonstrate that
channelrhodopsin-2 (ChR2) can be expressed stably and
safely in human embryonic stem cells (hESC), which can
then be differentiated into cardiomyocytes (hESCChR2-CM).
Upon photostimulation, ChR2 opens rapidly and allows
sodium ions to enter the cell, inducing a defined transmem-
brane potential, commonly known as the action potential.
We illustrate how ChR2 can be introduced into a computa-
tional autorhythmic cell model via an additional photocurrent
governed by a light-sensitive gating variable to simulate thisdoi: 10.1016/j.bpj.2011.08.004
FIGURE 1 Channelrhodopsin-2 (ChR2) is a light-gated cation channel
native to the green alga C. reinhardtii. It consists of seven transmembrane
proteins and absorbs light through its interaction with retinal. Here, we
induce channelrhodopsin coupled to enhanced yellow fluorescent protein
(eYFP) into undifferentiated human embryonic stem cells via a lentiviral
vector and differentiate these cells into cardiomyocytes.
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ducing photostimulation amplitudes, pulse widths, and fre-
quencies from single action potential readings. Using a
custom-designed finite element model, we virtually inject
our calibrated model cells into different locations of a human
heart to illustrate the potential of the proposed approach
toward pacing hearts with light.MATERIALS AND METHODS
All experiments, methods, and protocols for this study were approved by
the Stanford University Stem Cell Research Oversight committee.Opsin sources and lentiviral vector
The channelrhodopsin-2 (ChR2) variant described here was optimized for
mammalian expression by truncating the native sequence from 2241 base-
pair (bp) to 933 bp, by changing the native histidine (H) codon (CAC) to the
arginine (R) codon (CGC) coding for protein residue 134 of ChR2
(H134R), and by changing its gene’s codon usage to conform to human
codon usage distribution (15,16). The lentiviral vector pLenti-EF1a-
ChR2-eYFP-WPRE (pLECYT) was constructed as previously described
(7,16). The pLET plasmid contains the ubiquitously expressed elongation
factor 1-alpha (EF1a), to obtain high levels of ChR2-eYFP expression inFIGURE 2 Channelrhodopsin-2 (ChR2) is activated by photoisomeriza-
tion of all-trans retinal to 13-cis retinal at wavelengths of 470 nm. After
photoisomerization, the covalently bound retinal spontaneously relaxes to
all-trans in the dark, providing closure of the ion channel and regeneration
of the chromophore.a mammalian system ((8), O. Abilez, J. A. Baugh, M. L. Gorrepati,
R. Prakash, C. Lee-Messer, M. Huang, F. Jia, J. Yu, K. D. Wilson, J. C. Wu,
K. Deisseroth, and C. K. Zarins, unpublished). All constructs have been fully
sequenced previously for accuracy of cloning (7,15). High-titer lentivirus
was produced using a second-generation lentiviral system by cotransfection
of 293FT cells (Invitrogen, Carlsbad, CA), the pLECYT viral vector
described above, pCMVRD8.74 (containing GAG and POL), pMD2.G (con-
taining VSVg), and calcium phosphate as previously described (16,17).Stem cell culture and differentiation
Channelrhodopsin-expressing human embryonic stem cells (hESCChR2þ)
were grown as monolayers (O. Abilez, J. A. Baugh, M. L. Gorrepati, R. Pra-
kash, C. Lee-Messer, M. Huang, F. Jia, J. Yu, K. D.Wilson, J. C. Wu, K. De-
isseroth, and C. K. Zarins, unpublished) on hESC-qualified Matrigel (BD
Biosciences, San Jose, CA) and maintained in the pluripotent state through
daily feeding with mTeSR1 media (StemCell Technologies, Vancouver,
British Columbia, Canada) (18), supplemented with 1 penicillin/strepto-
mycin (Invitrogen). Cardiomyocyte differentiation was usually begun
2–5 days after initially seeding hESCChR2þ on Matrigel (BD Biosciences).
At this time, the cells were transferred to RPMI-1640 media supplemented
with B27, 1 nonessential amino acids, 1 penicillin/streptomycin, and
0.1 mM b-mercaptoethanol (all Invitrogen) and our differentiation
method was begun using aspects of other methods previously described
(19,20).
On the first day of differentiation, Day 0, RPMI media with 50 ng/mL of
Activin A (R&D Systems, Minneapolis, MN) was added to each well. On
the subsequent day, Day 1, 5 ng/mL of BMP-4 (R&D Systems) was added
to each well. On Day 3, fresh RPMI media was added to each well and
was replaced every 48 h until Day 11, when the cells were transferred to
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented
with 5% fetal bovine serum (Invitrogen), 1 nonessential amino acids,
1 penicillin/streptomycin, and 0.1 mM b-mercaptoethanol. This DMEM
was then replaced approximately every 48 h. Cardiomyocytes generally
began spontaneously beating between Days 9 and 20.Fluorescence-activated cell sorting
Fluorescence-activated cell sorting (FACS) was performed with a BD
FACSAria instrument equipped with BD FACSDiva 6.0 software (BD
Biosciences). Up to 1  106 cells transduced with the ChR2-eYFP lenti-
virus were sorted. Sorted cells were then resuspended in mTeSR1 media
and replated on Matrigel-coated wells. After 2–3 days in culture, enhanced
yellow fluorescent protein (eYFP) signal was confirmed via fluorescence
microscopy. Analysis of FACS datawas performed offlinewith FlowJo 7.6.1
software (Tree Star, Ashland, OR).Polymerase chain reaction
For undifferentiated hESC, polymerase chain reaction (PCR) primers with
gene product length for the following genes were used: GAPDH (152 bp),
Oct-4 (169 bp), Nanog (154 bp), a region within eYFP (187 bp), a region
spanning eYFP-ChR2 (197 bp), and a region within ChR2 (174 bp). Total
RNAwas isolated and RNA yield was then quantified using a Quant-iT kit
(Invitrogen) and Qubit fluorometer (Invitrogen) per the manufacturer’s
instructions. For cDNA synthesis, 1 mg total RNA, random hexamers, an-
nealing buffer, 2 First-Strand Reaction Mix (Invitrogen) and SuperScript
III/RNase OUT Enzyme Mix (Invitrogen), and RNase/DNase-free water
were combined, then incubated per the manufacturers instructions. For
PCR amplification, AccuPrime Pfx SuperMix (Invitrogen), custom primers
for pluripotency markers as described above, and cDNA were combined.
Nontemplate control reactions were prepared by substituting cDNA with
distilled water. Samples were transferred to a thermal cycler and the
following cycling program was used: 1), initial denaturation at 95C forBiophysical Journal 101(6) 1326–1334
1328 Abilez et al.2 min; 2), 30 cycles of 95C for 30 s, 60C for 30 s, and 68C for 1 min;
and 3), final extension at 68C for 5 min.
Finally, PCR products, a 100-bp ladder (Invitrogen), and nontemplate
control reactions were loaded in separate wells of a 2% agarose E-gel
with SYBR-Safe (Invitrogen) and run for 30 min. Bands were then visual-
ized with an E-gel iBase blue-light transilluminator (Invitrogen).Immunocytochemistry
Human-embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) were
labeled with primary antibodies for the cardiac markers a-actinin (IgG,
1:500; Sigma, St. Louis, MO) and troponin I (TnI) (IgG, 1:200; Millipore,
Billerica, MA). The secondary antibody used was goat anti-mouse IgG-
Alexa 594 (1:1000; Invitrogen) for both a-actinin and TnI. Cells were coun-
terstained with 40,6-diamidino-2-phenylindole (DAPI, Sigma) for 10 min.
An AxioObserver Z1 (Carl Zeiss, Go¨ttingen, Germany) inverted micro-
scope was used to visualize hESC-CMs. The Zeiss microscope was equip-
ped with a Lambda DG-4 300 W Xenon light source (Sutter Instruments,
Novato, CA), an ORCA-ER charge-coupled device camera (Hamamatsu,
Bridgewater, NJ), and AxioVison 4.7 software (Zeiss).Optical stimulation
Optical stimulation was delivered to hESC-CMs via a Lambda DG-4 300W
Xenon light source (Sutter Instruments) or with a 470 nm LED at
7 mW/mm2 (Thorlabs, Newton, NJ). For multielectrode array (MEA) elec-
trophysiology, optical stimulation consisted of a monophasic waveform
with peak amplitude of 0, 33, 75, or 100% of maximum power
(10 mW/mm2 for 40 objective), pulse width of 100 ms, and frequency
of 0.5, 1.0, or 1.5 Hz. For whole-cell patch-clamp electrophysiology, optical
stimulation consisted of a monophasic waveform with peak amplitude of
0, 12.5, 25, 50, or 100% of maximum power (10 mW/mm2 for 40 objec-
tive) and a pulse width of 1000 ms. Optical power delivered to cells at each
microscope objective was measured with a digital power meter (Thorlabs)
at the focal plane of the objective.Multielectrode array electrophysiology
Multielectrode arrays (MEA) with sixty 30-mm titanium nitride electrodes
equally spaced 200-mm apart, with indium tin oxide leads, and with an
internal reference (Thin MEA 200/30 iR indium tin oxide; MultiChannel
Systems, Reutlingen, Germany) were coated with 25 mg/mL fibronectin
(Sigma). Desired cardiomyocyte (CM) colonies were then manually
dissected off their plates, transferred to the MEAs, and allowed to attach.
A single MEA containing cells and Tyrode’s solution (Sigma) was then
placed in the amplifier (MEA 1060-Inv-BC; MultiChannel Systems) for
recordings. Signals were acquired at 1 kHz from a USB-6225 M Series
DAQ (National Instruments, Austin, TX). Videos of contracting CM were
captured at 30 fps for a duration of 1–30 s with a Retiga 2000R Color
Cooled Camera (QImaging, Surrey, British Columbia, CA). The MEA
amplifier was configured with MEA Select 1.1.0 software (MultiChannel
Systems) and electrical and video signals were acquired and controlled
with a custom program created with LabVIEW 2009 (National Instru-
ments). To visualize hESC-CM contractions, a custom edge detection algo-
rithm in LabVIEW 2009 (National Instruments) was used to detect rising
and falling edge locations along a grayscale profile generated from
a user-defined region of interest based on a user-defined threshold value.
FIGURE 3 Three-state model for the channelrhodopsin photocycle.
Upon photoabsorption, molecules in the closed state gc undergo a fast tran-
sition into the open state gChR2. After for some time, molecules spontane-
ously turn into the recovering state gr where the ion channels are closed,
but the molecules are not yet ready to photoswitch again. After a recovery
period, the molecules finally return to the closed state gc, ready to undergo
a new photocycle when subjected to light.Patch-clamp electrophysiology
hESC-CMs were recorded by means of whole-cell patch-clamp, using an
Axon Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA),
an Axon Digidata 1440A data acquisition system (Molecular Devices),Biophysical Journal 101(6) 1326–1334and pClamp 10 software (Molecular Devices) as previously described
(15,21). Cells were visualized and optically stimulated on an Olympus
upright microscope equipped with a 470 nm LED (Thorlabs) and EXFO
X-Cite halogen light source (Lumen Dynamics, Mississauga, Ontario,
Canada) through a 40/0.8 NA water immersion objective. When using
the halogen light source coupled to a shutter (VCM-D1; Uniblitz, Roches-
ter, NY), an excitation filter of HQ470/40, dichroic Q495LP (Chroma Tech-
nology, Bellows Falls, VT) was used for delivering blue light for ChR2
activation (10, 5, 2.5, 1.25 mW/mm2). eYFP was visualized with a standard
eYFP filter set (excitation 500/20, dichroic 515LP, emission 535/30;
Chroma Technology). Borosilicate glass (Sutter Instruments) pipette resis-
tance ranged from 3 to 6 MU.
Whole-cell patch-clamp recordings were performed as previously
described (15), using the intracellular solution: 129 mM K-gluconate,
10 mM HEPES, 10 mM KCl, 4 mM MgATP, 0.3 mM NaGTP, titrated to
pH 7.2; and extracellular Tyrode’s solution: 125 mM NaCl, 2 mM KCl,
3 mM CaCl2, 1 mM MgCl2, 30 mM glucose, and 25 mM HEPES, titrated
to pH 7.3. For voltage-clamp recordings, cells were held at 70 mV. All
experiments were performed at room temperature, 22–25C. Fluorescent
cells were patched immersed in Tyrode’s solution containing 5–10 mMbleb-
bistatin to eliminate contractility while preserving electrical activity (22).
Patch-clamp data were analyzed using ClampFit 10.2 (Molecular Devices).Mathematical model of channelrhodopsin
photocycle
To model the channelrhodopsin photocycle, we adopt a three-state photo-
cycle model (23,24), which is characterized through an open, a closed
but still recovering, and a fully closed state (4), as illustrated in Fig. 3.
Upon photoabsorption, molecules that are in the closed state gc undergo
a fast transition into the open state gChR2. After being open for some
time, molecules spontaneously transition into the recovering state gr, where
the ion channels are closed, but the molecules are not yet ready to photo-
switch again. After a recovery period, the molecules finally return to the
closed state gc, ready to undergo a new photocycle when exposed to light
(25). Fig. 3 suggests the following first-order model for the channelrhodop-
sin photocycle:
_gChR2 ¼ 3npho gc  Gr gChR2
_gr ¼ Gr gChR2  Gc gr
_gc ¼ Gc gr  3npho gc:
(1)
Here Gr and Gc are the rates of recovery and full closure, 3is the quantum
efficiency of the channelrhodopsin system, and n is the number ofpho
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tion of molecules in the open, recovering, and closed states, scaled such that
they sum up to one, gChR2 þ gr þ gc ¼ 1. This implies that the photocycle
system (Eq. 1) can be characterized through two independent variables,
e.g., the fraction of molecules in the open and in the recovering states:
_gChR2 ¼ 3npho

3npho þ Gr

gChR2  3npho gr
_gr ¼ Gr gChR2  Gc gr:
(2)
We identify the state gChR2 as the channelrhodopsin gating variable and
integrate it into a well-defined autorhythmic cell model (26) characterizedthrough ngate ¼ 10 gating variables in total as illustrated in Fig. 4:
ggate ¼
h
gm; gh; gChR2; gy; gx; gdL; gfL; gfCa; gdT; gfT
i
: (3)
These are the fast sodium channel activation gate gm, the fast sodium
channel inactivation gate gh, the channelrhodopsin activation gate gChR2,
the hyperpolarization activated inward current activation gate gy, the de-
layed rectifier current activation gate gx, the long-lasting calcium channel
activation gate gdL, the voltage-dependent long-lasting calcium channel in-
activation gate gfL, the calcium-dependent long-lasting calcium channel
inactivation gate gfCa, the transient calcium channel activation gate gdT,
and the transient calcium channel inactivation gate gfT. The gating variables
are parameterized in terms of the transmembrane potential f, the ionic
concentrations cion, and the gating variables ggate themselves. Their evolu-
tion is governed by classic Hodgkin-Huxley type equations,
_ggate ¼
1
tgateðfÞ
h
gNgateðf; cionÞ  ggate
i
; (4)
each characterized through a steady-state value gNgate and a time constant
tgate for reaching this steady state (27). Both are usually exponential func-
tions of the transmembrane potential f.FIGURE 4 Ionic model of genetically engineered light sensitive cardiac
cell. The electrochemical state of the cell is characterized in terms of nion¼
8 ion concentrations, cion ¼ [ceNa, ceK, ceCa, ciNa, ciK, ciCa, cupCa, crelCa], the
extracellular and intracellular sodium, potassium, and calcium concentra-
tions, and the sarcoplasmic reticulum calcium uptake and release. Ion
concentrations are controlled through ncrt ¼ 12 ionic currents, Icrt ¼ [INa,
IbNa, If, INaCa, INaK, IChR2, IK, IbK, ICaL, ICaT, Iup, Irel], where the baseline
autorhythmic cell model (26) has been enhanced with the channelrhodopsin
current IChR2 (shown in blue). The channels are governed by ngate ¼ 10
gating variables ggate ¼ [gm, gh, gChR2, gy, gx, gdL, gfL, gfCa, gdT, gfT], which
may be functions of the current membrane potential f.Mathematical model of ionic currents
The channelrhodopsin gating variable gChR2 introduced in the previous
section governs the channelrhodopsin current IChR2, for which we make
the following Ansatz:
IChR2 ¼ CChR2 gChR2½f fChR2: (5)
Here, CChR2 is the channelrhodopsin conductance and fChR2 is the reversal
potential of channelrhodopsin (see the Supporting Material). We integratethe channelrhodopsin current IChR2 into an autorhythmic cardiac cell model
(26,28), defined through a total of ncrt ¼ 12 ionic currents,
Icrt ¼

INa; IbNa; If ; INaCa; INaK; IChR2; IK; IbK; ICaL; ICaT; Iup; Irel

;
(6)
which are, mathematically speaking, functions of the transmembrane poten-
tial f, the individual gating variables ggate, and the ion concentrations cion:Icrt ¼ Icrt

f; ggate; cion

: (7)
These 12 ionic currents consist of 10 transmembrane currents, i.e., the fast
sodium current INa, the background sodium current IbNa, the hyperpolariza-tion-activated sodiumandpotassiumcurrents If, the sodiumcalciumexchanger
current INaCa, the sodium potassium pump current INaK, the channelrhodopsin
sodium current IChR2, the delayed rectifying potassium current IK, the back-
ground potassium current IbK, the long-lasting L-type calcium current ICaL,
and the transient T-type calcium current ICaT, and two sarcoplasmic reticulum
currents, i.e., the calcium uptake Iup and the calcium release Irel.Mathematical model of ionic concentrations
From a chemical point of view, light induces a channelrhodopsin current
IChR2, which directly impacts the intracellular sodium concentrations c
i
Na,
_ciNa ¼ 
1
FVi

INa þ IbNa þ IfNa þ 3INaCa þ 3INaK
þ IKNa þ IChR2

;
(8)
where Vi is the cytosolic volume and F is the Faraday constant. The sodium
concentration will directly, and indirectly through the resulting changes inthe transmembrane potential f, affect all other ionic concentrations in the
cell. The biochemistry of our cell model is characterized through nion ¼
8 ion concentrations,
cion ¼

ceNa; c
e
K; c
e
Ca; c
i
Na; c
i
K; c
i
Ca; c
up
Ca; c
rel
Ca

; (9)
defined in terms of their evolution equations,_cion ¼ _cion

f; ggate; cion

; (10)
which are parameterized in terms of the transmembrane potential f, thegating variables ggate, and the ion concentrations cion themselves. In partic-
ular, ceNa, c
e
K, and c
e
Ca are the extracellular sodium, potassium, and
calcium concentrations; ciNa, c
i
K, and c
i
Ca are the intracellular sodium,
potassium, and calcium concentrations; and cupCa and c
rel
Ca are the sarco-
plasmic reticulum calcium uptake and release (see the Supporting Material
for details about the cell model and its material parameters).Mathematical model of action potential
propagation
From an electrical point of view, light induces a channelrhodopsin current
IChR2, which directly impacts the action potential propagation f in the heart.Biophysical Journal 101(6) 1326–1334
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potential is a global field variable (29). Its spatiotemporal evolution
_f ¼ f f

f; ggate; cion

þ div qðfÞ (11)
is driven by a local source term f f at the single cell level, and by a global
flux term, div q, the divergence of the propagation vector q at the organ 200 µm
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z z z
z
z
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a b
dclevel. The local source term
f f ¼  1
C

INa þ IbNa þ If þ INaCa þ INaK þ IChR2
þ IK þ IbK þ ICaL þ ICaT
 (12)
is directly related to the negative sum of all transmembrane currents scaled
by the individual cell membrane capacitance per unit surface area C. To
account for the nonlocal nature of propagating excitation waves in the heart,
we introduce the propagation vector
q ¼ D$Vf (13)
through the second-order diffusion tensor D scaling the gradient of the
action potential field Vf (see the Supporting Material for the finite-
element-based solution of the action potential propagation problem, and
see (27,29,30)).400 µm1 µm fe
FIGURE 5 Undifferentiated human embryonic stem cells (hESC) stably
transduced with a ChR2-eYFP lentiviral vector (hESCChR2þ) remain plurip-
otent and can differentiate into cardiomyocytes (hESCChR2þ-CM). (a) PCR
shows that hESC ChR2þ express the pluripotent Oct-4 gene (169 bp, lane 4)
and Nanog gene (154 bp, lane 5) (blue box). In addition, amplification
within the ChR2 gene (174 bp, lane 6), across the ChR2-eYFP gene
(197 bp, lane 7), and within the eYFP gene (187 bp, lane 8), confirms stable
transduction of the ChR2-eYFP lentivirus in undifferentiated hESCChR2þ
(yellow box). A ladder (100 bp, lane 1) confirms the predicted sizes of
PCR products. Nontemplate control (lane 2) and GAPDH (152 bp, lane
3) serve as negative and positive controls, respectively. (b) Pluripotent
hESCChR2þ stain is positive for alkaline phosphatase (red). (c) Fluorescence
microscopy shows hESCChR2þ has a positive eYFP signal (green). (d)
hESCChR2þ-CM have positive TnI signals (red), consistent with a CM
phenotype. DAPI staining (blue) demonstrates the position of nuclei. (e)
Transmission electron microscopy shows sarcomeres with associated
z-lines (z) and mitochondria (m) in hESCChR2þ-CM. (f) Light microscopy
shows three hESCChR2þ-CM colonies (dashed white circles) on a multielec-
trode array.RESULTS
Fig. 5 demonstrates our ability to stably transduce undiffer-
entiated hESC with a ChR2-eYFP lentiviral vector. The re-
sulting hESCChR2þ remain pluripotent and can differentiate
into hESCChR2þ-CM. In Fig. 5 a, the PCR shows that
hESCChR2þ express the pluripotent Oct-4 gene (169 bp,
lane 4) and Nanog gene (154 bp, lane 5) (blue box). In addi-
tion, amplification within the ChR2 gene (174 bp, lane 6),
across the ChR2-eYFP gene (197 bp, lane 7), and within
the eYFP gene (187 bp, lane 8), confirms stable transduction
of the ChR2-eYFP lentivirus in undifferentiated hESCChR2þ
(yellow box). A ladder (100 bp, lane 1) confirms the pre-
dicted sizes of PCR products. Nontemplate control (lane
2) and GAPDH (152 bp, lane 3) serve as negative and
positive controls, respectively. Fig. 5 b illustrates that
pluripotent hESCChR2þ is stain-positive for alkaline phos-
phatase (red). Fig. 5 c demonstrates the hESCChR2þ positive
eYFP signal upon fluorescence microscopy (green). Fig. 5 d
confirms that hESCChR2þ-CM have positive TnI signals
(red), consistent with a CM phenotype. DAPI staining
(blue), demonstrates the position of nuclei. Fig. 5 e illus-
trates transmission electron microscopy of hESCChR2þ-CM
showing sarcomeres with characteristic z-lines and mito-
chondria. Fig. 5 f shows the light microscopy of three
hESCChR2þ-CM colonies (dashed white circles) on a multi-
electrode array.
Fig. 6 demonstrates the experimental and computational
sensitivity of hESCChR2-CM with respect to different light
intensities. With light on, the photocurrent IChR2 increases
rapidly, peaks, and decays toward a characteristic plateau
value. With light off, the photocurrent IChR2 drops rapidly
and decays to zero. Fig. 6 (top) illustrates the varying lightBiophysical Journal 101(6) 1326–1334intensities from 12.5% to 25%, 50%, and 100% for which
we measure the photocurrent IChR2 upon whole-cell voltage-
clamp. Fig. 6 (middle) demonstrates the experimentally
measured photocurrent IChR2, which increases with in-
creasing light intensity. Fig. 6 (bottom) shows the calibrated
computational cell model that captures the characteristic
light sensitivity, displaying increased photocurrents IChR2
with increased light intensity (see the Supporting Material).
Fig. 7 demonstrates the experimental and computational
sensitivity of hESCChR2-CMwith respect to different stimula-
tion frequencies. Applied light stimulation at 100% intensity
is illustrated (blue lines) at 100-ms pulse width. Experimen-
tally measured electrical field potentials and mechanical
contractions (black and red lines) and computationally pre-
dicted electrical transmembrane potentials are indicated
FIGURE 6 Experimental and computational sensitivity of hESCChR2-
CM with respect to light intensity. With light on, the photocurrent IChR2
increases rapidly, peaks, and decays toward a characteristic plateau value.
With light off, the photocurrent IChR2 drops rapidly and decays to zero.
Light intensity is varied from 12.5% to 25%, 50%, and 100% (top).
Whole-cell voltage-clamp reveals an increased photocurrent IChR2 as the
light intensity increases (middle). The computational hESCChR2-CM model
captures the light sensitivity and displays increased photocurrents IChR2
with increased light intensity (bottom).
FIGURE 7 Experimental and computational sensitivity of hESCChR2-
CM with respect to stimulation frequency. Light stimulation (blue) evokes
field potentials (black) that translate into mechanical contractions (red).
Light stimulation at 100% intensity is performed at 0.5 Hz (top), 1.0 Hz
(middle), and 1.5 Hz (bottom). Evoked signals during light stimulation
(center) are markedly different from pre- and poststimulation signals at
all frequencies (left and right). The computational hESCChR2-CM model
(green) captures the electrical signal at all frequencies, both during light
stimulation (center), and pre- and poststimulation (left and right).
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0.5 Hz (Fig. 7, top), 1.0 Hz (Fig. 7, middle), and 1.5 Hz
(Fig. 7, bottom). Electrical and mechanical signals during
light stimulation, shown in the center, are significantly
different from pre- and poststimulation signals at all frequen-
cies, shown at the beginning and end of the readings. The
computational hESCChR2-CM model excellently captures
the electrical signal both during light stimulation, and pre-
and poststimulation. The two initial double spikes (see green
curves) of the computationalmodel paced at 0.5Hz are caused
by an interference of the photostimulation with the cell’s
natural frequency of 0.7 Hz. This interference is only present
when cells are paced below their natural frequency, and
does not occur during photostimulation at 1.0 Hz and 1.5 Hz.
Fig. 8 illustrates the potential of the proposed technology
to virtually pace a human heart with light. The finite element
model of the heart created from magnetic resonance images
consists of 3129 nodes and 11,347 three-dimensional
tetrahedral elements (31) (see the Supporting Material).
Fig. 8 (top) shows the effects of atrioventricular (AV)
node photostimulation initiated through hESCChR2-CM,
which are virtually injected into the basal region of the
septum, whereas all other regions are modeled as standard
ventricular CM. For AV node pacing, the depolarization
wave is initiated at the AV node, travels down the septum,and then activates the left and right ventricles. Fig. 8
(bottom) shows the effects of biventricular photostimula-
tion, initiated through hESCChR2-CM, which are virtually
injected into the lateral wall of the left and right ventricles,
whereas all other regions are modeled as standard ventric-
ular CM. For biventricular photostimulation, the depolariza-
tion wave is initiated at the lateral left and right ventricular
walls, travels along the ventricles, and then activates the
apex and the septum. The color code indicates theBiophysical Journal 101(6) 1326–1334
FIGURE 8 Virtual activation sequences of light-paced hearts. Atrioven-
tricular node (top) and biventricular (bottom) photosimulations are initiated
through hESCChR2-CM, virtually injected into the basal septum and into
both lateral walls, respectively. All other regions are modeled as standard
ventricular CM. The color code indicates the magnitude of the transmem-
brane potential f varying from 90 mV (blue) to þ20 mV (red).
1332 Abilez et al.magnitude of the transmembrane potential varying from
90 mV (blue) to þ20 mV (red).DISCUSSION
In Fig. 5, we have shown that ChR2 can be expressed stably
and safely in hESC-CM to drive CM depolarization via pho-
tostimulation. Using a lentiviral vector (7,16), we have
introduced ChR2 coupled to YFP into undifferentiated
hESC. After confirming expression via immunocytochem-
istry, we have expanded these ChR2-expressing cells and
demonstrated their pluripotency using PCR. Via directed
differentiation, we have created hESCChR2-CM, which we
have then subjected to optical stimulation. We have success-
fully recorded their electrical, biochemical, and mechanical
signals using patch-clamping, MEA recordings, and video
microscopy. These data have allowed us to calibrate our
computational hESCChR2-CM model.
In Fig. 6, we have demonstrated the sensitivity of both
experimental and computational photocurrents with respect
to the stimulating light intensity (25). Both graphs illustrate
the characteristic rapid increase to the intensity-dependent
peak current, followed by a slower decrease toward the
intensity-dependent asymptotic plateau value (32,33).Biophysical Journal 101(6) 1326–1334Although the translation of optogenetic techniques into
clinical practice may still have many technical hurdles to
pass, the technology itself can already serve as a valuable
research tool in cardiac electrophysiology. Traditional tools
based on the simultaneous use of electrical stimulation and
electrical recording typically suffer from unavoidable arti-
facts (34). The inherent orthogonality of optical and electri-
cal techniques allows us to significantly reduce these
spurious errors when using optical stimulation combined
with electrical recordings, as shown in Fig. 7.
A tremendous potential of opsin-based systems for
optical manipulation lies in their inherent ability to not
only turn-cells-on using channelrhodopsin as a blue-light-
gated ion channel transporting positively charged cations
along their concentration gradients (9), but also to turn-
cells-off using halorhodopsin as a yellow-light-driving ion
pump transporting negatively charged chloride ions against
their concentration gradients (10). A promising first study in
zebrafish has shown that a combination of channelrhodopsin
and halorhodopsin allows for optically controlling heart
rate, reversing cardiac conduction, and inducing diseaselike
arrhythmias (14).
Computational modeling allows us to predict the response
of living cells, both in isolation and in interaction with their
environment. In Fig. 8, we have demonstrated our very first
proof-of-principle, using finite element modeling in an
attempt to bridge the scales from cells to systems (35).
Finite-element-based models allow us to combine virtually
any cell type (36) on virtually any geometry (37). Here,
they allow us to predict the activation sequences in the
human heart for different pacing sites (38).
Pacing hearts in silico by means of photostimulation will
allow us to virtually probe different scenarios (39,40) toward
our ultimate goal of light pacing hearts in vivo (14). In
contrast to electrical pacemakers, light delivery is minimally
invasive, genetically targeted, and temporally precise. Most
importantly, light can be delivered at a distance. Unlike
pacing leads for electrical stimulation, which are known to
have a high failure rate due to mechanical fatigue (41), the
light source for optical stimulation does not have to sit
directly on the continuously moving heart muscle. Light
pacing might therefore be an attractive remote, less invasive,
and more durable alternative to current electrical pacing
leads (42).Limitations
This study presents our first attempts toward pacing the
heart with light using a multiscale approach. On the photo-
cycle level (4), we have adapted a classic three-state model
for the ChR2 photocycle, which was initially proposed for
ChR2-expressing neurons. This conceptually elegant model
has allowed us to reliably reproduce the characteristic
features of a light-evoked response in ChR2-expressing
hESC-CM. However, the extension to a four-state (24) or
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the biexponential decay of the light-off current more accu-
rately (23), is conceptually straightforward. In terms of pho-
tostimulation, we have applied pulse widths of 100 and
1000 ms. These relatively long durations of channel opening
may increase sodium overload and adversely influence
action potential profiles. Because the rapid upstroke of the
action potential takes place in the first 10 ms (26), the stim-
ulation pulse width could potentially be decreased to 10 ms
or less (O. Abilez, J. A. Baugh, M. L. Gorrepati, R. Prakash,
C. Lee-Messer, M. Huang, F. Jia, J. Yu, K. D. Wilson,
J. C. Wu, K. Deisseroth, and C. K. Zarins, unpublished),
which would favorably limit light exposure time (see the
Supporting Material). Novel developments in ultrafast
optogenetics suggest using the rationally engineered chan-
nelrhodopsin ChETA, which provides high-fidelity optical
control of spiking at high frequencies and eliminates plateau
potentials during continued stimulation (44).
On the ion channel level, we have assumed that the ChR2
current is driven exclusively by concentration gradients
in the sodium concentration (24). Accordingly, we have
modeled ChR2 to be selectively permeable to sodium ions
only. Although ChR2 is known to be a general cation
channel (12), its effects on potassium and calcium remain
poorly characterized (45). However, making the channel
permeable to other monovalent and divalent cations (4),
would require only modular changes in the mathematical
model.
On the cellular level, due to the lack of mathematical
models for stem cell-derived cardiac cells, we have adopted
a widely used and well-characterized model for mature
cardiac cells (26,28). A recent study confirmed that ChR2
expresses its characteristic features independent of the
particular expression system (45). Therefore, we have modi-
fied the mature cell model via an additional photocurrent
governed by a light-sensitive gating variable. A thorough
identification of the individual channel characteristics of
hESC-CM and their quantitative comparison with mature
CM and hESCChR2þ-CM remain to be addressed to fully
validate our conceptual approach (21).
On thewhole-heart level, the simulation of the light-paced
heart is admittedly relatively simplistic. Although our algo-
rithm can, in principle, handle arbitrary mixtures of different
cell types (36), here, we have assumed that the injected cells
are pure hESCChR2þ-CM.Wehave adopted a common proce-
dure to model cell injection (37), which does not address
additional obstacles commonly associated with cell delivery
such as cell migration away from the injection site or cell
survival in the myocardial wall. At this stage, our model
also fails to appropriately predict the effects of light scat-
tering by tissue and absorption by blood. Light scattering is
a general barrier to in vivo translation, and efforts are
underway by our groups and others to red-shift the opsins
and maximize the efficiency of light delivery through tissues
(15,46).CONCLUSION
At an unprecedented temporal and spatial precision, optoge-
netic tools now enable us to manipulate electrically active
cells. This study capitalizes on recent developments in
optics and genetics, supplemented by novel technologies
in stem cell biology, electrophysiology, and computational
mechanics. It documents our first attempts to introduce a
light-sensitive ion channel in human-embryonic-stem-cell-
derived cardiomyocytes, with the ultimate goal to control
the cardiac system by means of photostimulation. Unlike
traditional electrical stimulation, optogenetics allows us to
precisely control the selective permeability of the plasma
membrane, its conductivity with respect to different ions,
its sensitivity to light of different wavelengths, and the
spatiotemporal evolution of different opening and closing
profiles. Given this incredible freedom, we need to establish
an economical strategy to optimize the matrix of input
variables. Predictive computational models allow us to
virtually probe landscapes of process parameters and
identify optimal photostimulation sequences in various
different tissues and organs. Here, as a very first proof-of-
principle, we virtually inject photosensitive cells into
different locations of a human heart model, and pace the
heart with light. We believe that this concept will be widely
applicable to systematically manipulate electrically active
cells and, ultimately, support the design of novel therapies
for various types of neuronal, musculoskeletal, pancreatic,
and cardiac disorders such as depression, schizophrenia,
cerebral palsy, paralysis, diabetes, pain syndromes, and
cardiac arrhythmias.SUPPORTING MATERIAL
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